(Incorporated in the Cayman Islands)

We are a newly organized blank check company, or SPAC. As our name indicates, we are the third SPAC under the Helix name We intend to focus on the healthcare sector and healthcare-related industries in our search for a suitable target company. Our search will focus on the biotech, med tech and life science sectors.

Bihua Chen is our CEO and chairman of the board of directors. He is the founder and managing member of Cormorant Asset Management, a healthcare investment firm.

Caleb Tripp is our CFO and COO. He is the CFO of Cormorant. 

(Note: Helix Acquisition Corp. III disclosed its plans for its SPAC IPO on Dec. 8, 2025, in an S-1 filing: 12.5 million shares at $10.00 each to raise $125 million. Note: Helix Acquisition III is unusual  in that it is a stock-only offering. Most SPAC IPOs are structured as unit offerings with each unit consisting of a share of stock and a warrant (or a fraction of a warrant) – or of a right to acquire a fraction of a share of stock – upon the consummation of an initial business combination.)